Tempus ECG-Low EF vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Tempus ECG-Low EF, is an AI-powered diagnostic aid focused on detecting signs of low left ventricular ejection fraction from standard 12-lead ECGs. In contrast, Tool B, Implicity's IM007, is a comprehensive cloud-based platform for remote cardiac monitoring, primarily aggregating data from cardiac implantable electronic devices to streamline workflows and manage alerts. While both leverage AI in cardiology and relate to heart failure, their distinct data inputs (standard ECGs vs. CIED data) and operational scopes make them adjacent rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Tempus ECG-Low EF (Tool A) analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%). IM007 (Tool B) aggregates data from various cardiac implantable electronic devices (CIEDs) for remote monitoring.
Tempus ECG-Low EF (Tool A) is an AI software that aids clinicians in identifying patients 40 years or older at risk of heart failure by detecting signs of low LVEF from ECGs. IM007 (Tool B) is a remote cardiac monitoring platform that streamlines workflows, reduces false alerts, and includes predictive AI for heart failure hospitalization risk (SignalHF) for patients with CIEDs.
Tempus ECG-Low EF (Tool A) features an AI-powered algorithm for ECG analysis to detect signs of low LVEF, providing a binary output. IM007 (Tool B) offers AI-driven alert management, an FDA-cleared ILR ECG Analyzer for ICM data, and SignalHF, an FDA-cleared predictive AI for heart failure hospitalization risk.
Tempus ECG-Low EF (Tool A) aids in identifying patients at risk of heart failure for further evaluation by providing a clear binary output from ECG analysis. IM007 (Tool B) offers smart workflow automation for tasks like billing, reporting, and scheduling, and significantly reduces false positives from CIED alerts.
Tempus ECG-Low EF (Tool A) is intended for patients 40 years or older at risk of heart failure, for use in clinical diagnostic settings. IM007 (Tool B) is designed for patients with cardiac implantable electronic devices (CIEDs) requiring remote monitoring and management.
More Comparisons
Backers
Who funded each tool's parent company.